Page last updated: 2024-11-03

procarbazine and Condition, Preneoplastic

procarbazine has been researched along with Condition, Preneoplastic in 2 studies

Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.

Research Excerpts

ExcerptRelevanceReference
"Despite the dramatic response of Hodgkin's disease to intensive chemotherapy, the skin lesion was rapidly transformed into squamous cell carcinoma in 10 weeks."1.26Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease? ( Poleksic, S; Yeung, KY, 1978)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koeppel, MC1
Horschowski, N1
Terrier, G1
Andrac, L1
Stoppa, AM1
Signoret, R1
Sayag, J1
Poleksic, S1
Yeung, KY1

Reviews

1 review available for procarbazine and Condition, Preneoplastic

ArticleYear
Lymphomatoid papulosis and Hodgkin's disease: report of a case.
    Dermatology (Basel, Switzerland), 1994, Volume: 189, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin D

1994

Other Studies

1 other study available for procarbazine and Condition, Preneoplastic

ArticleYear
Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease?
    Cancer, 1978, Volume: 41, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Therapy, Combination; Hodgkin Disease; Humans;

1978